These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enhancement by pituitary isografts of mammary hyperplastic nodules in adreno-ovariectomized mice. Yanai R, Nagasawa H. J Natl Cancer Inst; 1971 Jun; 46(6):1251-5. PubMed ID: 5088047 [No Abstract] [Full Text] [Related]
3. Effect of ergocornine on transplanted mammary tumor growth and pituitary prolactin level in BALB/c mice. Singh DV, Meites J, Halmi L, Kortright KH, Brennan MJ. J Natl Cancer Inst; 1972 Jun; 48(6):1727-31. PubMed ID: 5056256 [No Abstract] [Full Text] [Related]
4. Direct inhibition by ergocornine of pituitary prolactin release. Lu KH, Koch Y, Meites J. Endocrinology; 1971 Jul; 89(1):229-33. PubMed ID: 5089657 [No Abstract] [Full Text] [Related]
5. Prolactin and breast carcinoma. Smithline F, Sherman L, Kolodny D. N Engl J Med; 1975 Apr 10; 292(15):784-92. PubMed ID: 1089886 [Abstract] [Full Text] [Related]
6. Effects of 2-BR-alpha-ergokryptine (CB 154) on sex-linked rejection of pituitary isografts in female C57BL mice. Hoshino K. Experientia; 1973 Apr 10; 29(7):882-4. PubMed ID: 4146807 [No Abstract] [Full Text] [Related]
14. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine. Yanai R, Nagasawa H. J Natl Cancer Inst; 1970 Dec 10; 45(6):1105-12. PubMed ID: 5530649 [No Abstract] [Full Text] [Related]
15. Effects of ergocornine and 2-Br-alpha-ergokryptin (CB-154) on the formation of mammary hyperplastic alveolar nodules and the pituitary prolactin levels in mice. Yanai R, Nagasawa H. Experientia; 1970 Jun 15; 26(6):649-50. PubMed ID: 5424352 [No Abstract] [Full Text] [Related]
16. Relation of prolactin and estrogen to mammary tumorigenesis in the rat. Meites J. J Natl Cancer Inst; 1972 Apr 15; 48(4):1217-24. PubMed ID: 5023679 [No Abstract] [Full Text] [Related]